startup
UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics
Source:
eu-startups.com 1 min read
Share
You are reading a summary. The full content is hosted on eu-startups.com.
Thalia Therapeutics, a British BioTech company developing RNA-based therapeutics and delivery technologies in oncology and cardiovascular disease, has announced the acquisition of Sanmirna Therapeutics, alongside a €3.1 million (£2.75 million) raise. The round was supported by new and existing investors, including Premier Miton. The deal brings miRisten, a clinical-stage microRNA therapeutic candidate for Acute Myeloid […] The post UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics appeared first on EU-Startups.
Read the full article on the original website
External link to eu-startups.com
Related Articles
startup
Sources: Uber halts plans to launch food delivery in five of the seven European countries it had targeted for expansion as it pursues a Delivery Hero takeover (Kieran Smith/Financial Times)
1 min read •
startup
India issues a notice to Telegram, asking it to curb the spread of pirated films and other copyrighted content, and seeks an action-taken report within 15 days (Sejal Sharma/Hindustan Times)
1 min read •
startup
Trump's God, guns and anticommunist Fourth of July
2 min read •